Skip to main content
SpringerLink
Log in

The Bone Metastases Quality of Life Questionnaire

  • Reference work entry
Handbook of Disease Burdens and Quality of Life Measures

Abstract:

The Bone Metastases Quality of Life Questionnaire (BOMET-QOL) is the first bone metastases-specific HRQOL measure. It is a simple, self-administered questionnaire intended for use in clinical research and in the routine monitoring of patients with malignant bone disease due to neoplasia. The BOMET-QOL questionnaire is unidimensional and consists of 10 items that can be answered according to a Likert scale with five categories scoring from 0 to 4. The timeframe refers to “last week.” The items refer to HRQOL topics such as pain, mobility, vitality, sex life, worries about the future, perceptions and daily activities. The global score is calculated by adding up the answers obtained in each item, and may range from 0 (worst HRQOL) to 40 (best HRQOL). These scores are standardized to make it easier to interpret the scoring, with the final scores ranging from 0 (worst HRQOL) to 100 (best HRQOL). The BOMET-QOL was developed in three phases. The item generation phase was performed by means of a literature search, a panel of experts and 15 semi-structured interviews with patients. An initial set of 179 expressions was identified. The item selection phase consisted of the identification of the initial group of items. The 15 experts carried out a qualitative and quantitative reduction of the 179 expressions according to their clarity, frequency and importance. This phase resulted in the 35-item version of the BOMET-QOL. The item reduction phase was carried out in two steps. The initial reduction yielded a 25-item questionnaire. This was administrated to a non-randomized sample of 92 patients with malignant bone disease due to neoplasia (MBDN) and the reduction was carried out via factorial analysis. Similarly, the BOMET-QOL-25 was reduced to an integrated version of 10 items by means of a sample of 263 oncology patients. It was then validated, showing high homogeneity, good reproducibility and significant correlations with the ECOG and the EORTC-QLQ-C30 questionnaire. The BOMET-QOL questionnaire is a feasible (easy and user-friendly), reliable and specific 10-item instrument for assessing HRQOL in patients with MBDN.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 3,000.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

BM:

bone metastases

BOMET-QOL:

bone metastases quality of life questionnaire

CARES:

cancer rehabilitation evaluation system

FACT-G:

functional assessment of cancer therapy

HRQOL:

health-related quality of life

MBDN:

malignant bone disease due to neoplasia

PMI:

pain management index

QLQ- 30:

quality of life questionnaire

RSCL:

Rotterdam symptom check list

References

  • Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, M. de Haes JCJ, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F. (1993). J Natl Cancer Inst. 85: 365–376.

    Article  PubMed  CAS  Google Scholar 

  • Adrover E, Allepuz J, Sureda A, Domine M, Barnadas A, Constela M, Lluch A, Ruiz M, Piera J, Mayordomo JI, Morales A, Muñoz M, Alcover J, Colomer R, Llombart A, Massutti B, Carballido J, Garrido P, García R, Badia X, Lizan L, Gilabert M. (2005). J Outcomes Res. 9: 15–27.

    Google Scholar 

  • Avis NE, Smith KW, Hambleton RK, Feldman HA, Selwyn A, Jacobs A. (1996). Med Care. 34: 1102–1120.

    Article  PubMed  CAS  Google Scholar 

  • Badia X, Muriel C, Gracia A, Núñez-Olarte JM, Perulero N, Gálvez R, Carulla J, Cleeland CS, Vesbpi G. (2003). Med Clin (Barc). 120: 52–59.

    Article  Google Scholar 

  • Bezjak A, Taylor KM, Macdonald K, DePetrillo AD. (1998). Cancer Pre Control. 2: 230–235.

    CAS  Google Scholar 

  • Bunting RW, Shea B. (2001). Cancer. 92(Suppl. 4): 1020–1028.

    Article  PubMed  CAS  Google Scholar 

  • Cella D, Chang CH, Lai JS, Webster K. (2002). Semin Oncol. 29(Suppl. 8): 60–68.

    Article  PubMed  Google Scholar 

  • Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P and Brannon J. (1993). J Clin Oncol. 11: 570–579.

    PubMed  CAS  Google Scholar 

  • Cleeland CS. (1991). Cancer. 67: 823–827.

    Article  PubMed  CAS  Google Scholar 

  • Coleman R. (2004). Oncologist. 9: 14–27.

    Article  PubMed  CAS  Google Scholar 

  • Djulbegovic B, Wheatley K, Ross J, Clark O, Bos G, Goldschmidt H, Cremer F, Alsina M, Glasmacher A. (2002). Cochrane Database Syst Rev. 4: CD003188.

    Google Scholar 

  • Ganz PA, Schag CA, Lee JJ, Sim MS. (1992). Qual Life Res. 1: 19–29.

    Article  PubMed  CAS  Google Scholar 

  • Lipton A. (2003). Curr Treat Options Oncol. 4: 151–158.

    Article  PubMed  Google Scholar 

  • Martinez MJ, Roque M, Alonso-Coello P, Català E. (2003). Cochrane Database Syst Rev. 3: CD003223.

    PubMed  Google Scholar 

  • Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. (1982). Am J Clin Oncol. 5: 649–655.

    Article  PubMed  CAS  Google Scholar 

  • Prieto L, Alonso J, Lamarca R. (2003). Health Qual Life Outcomes. 28: 1–27.

    Google Scholar 

  • Rasch G. (1993). Probabilistic Models for Some Intelligence and Attainment Tests. Paedagogiske Institut, Copenhagen.

    Google Scholar 

  • Reddi AH, Roodman D, Freeman C, Mohla S. (2003). J Bone Miner Res. 18: 190–194.

    Article  PubMed  CAS  Google Scholar 

  • Sureda A, Isla D, Cózar JM, Ruiz M, Domine M, Margelí M, Edrover E, Ramos M, Pastor M, Martín A, Llombart A, Massuti B, Muñoz M, Barnadas A, Fernández J, Colomer R, Allepuz C, Gilabert M, Badia X. (2007). JME. 10: 27–39.

    Google Scholar 

  • Watson M, Law M, Maguire GP, Robertson B, Greer S, Bliss JM, Ibbotson T. (1992). Psychooncology. 1: 35–44.

    Article  Google Scholar 

Download references

Authors
  1. X. Badia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Vieta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Gilabert
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. Nutrition and Dietetics Nutritional Sciences Research Division School of Biomedical & Health Sciences, King's College London, Franklin‐Wilkins Building 150 Stamford Street, SE1 9NH, London, UK

    Victor R. Preedy (Prof.) (Prof.)

  2. Mel and Enid Zuckerman College of Public Health, University of Arizona, Health Science Center 1295 N. Martin, P.O. Box 245155, 85724-5155, Tucson, AZ

    Ronald R. Watson (Prof.) (Prof.)

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media LLC

About this entry

Cite this entry

Badia, X., Vieta, A., Gilabert, M. (2010). The Bone Metastases Quality of Life Questionnaire. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-78665-0_11

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-78664-3

  • Online ISBN: 978-0-387-78665-0

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation